Literature DB >> 2555183

Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence.

D Marc1, G Drugeon, A L Haenni, M Girard, S van der Werf.   

Abstract

Mutations were introduced by oligonucleotide-directed mutagenesis into the cDNA of poliovirus type 1 (Mahoney) in the region coding for the first five amino acids (myristoylation signal) of the viral capsid protein precursor P1. The cDNAs were then transcribed in vitro and the properties of the transcripts carrying the mutations studied in vitro by translation in a reticulocyte lysate or in vivo upon transfection of primate cells. Mutation of amino acid residue number 5 (Ser5----Thr) did not affect the viral phenotype, whereas mutations of residues number 1 (Gly1----Arg), 2 (Ala2----Pro) or 5 (Ser5----Pro) prevented myristoylation of P1 and were lethal. However, delayed production of virus was occasionally observed as the result of reverse mutations, which were found to restore a functional myristoylation signal as well as a wild-type virus phenotype. Thus, the myristoylation signal of the poliovirus polyprotein can accommodate Ala, Ser, Thr or Leu residues at position 2 and Ser, Thr or Ala residues at position 5. Mutations that altered myristoylation of P1 and affected virus viability did not prevent replication of the viral RNA but severely impeded in vitro processing of P1. This suggests that myristoylation plays a role in poliovirus capsid protein assembly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555183      PMCID: PMC401272          DOI: 10.1002/j.1460-2075.1989.tb08406.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Early alteration of poliovirus in infected cells and its specific inhibition.

Authors:  K Lonberg-Holm; L B Gosser; J C Kauer
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

Review 3.  The biology and enzymology of eukaryotic protein acylation.

Authors:  D A Towler; J I Gordon; S P Adams; L Glaser
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  The formation of poliovirus particles in association with the RNA replication complexes.

Authors:  L A Caliguiri; R W Compans
Journal:  J Gen Virol       Date:  1973-10       Impact factor: 3.891

5.  Early interaction of rhinoviruses with host cells.

Authors:  K Lonberg-Holm; B D Korant
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

6.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Lambdoid phages that simplify the recovery of in vitro recombinants.

Authors:  N E Murray; W J Brammar; K Murray
Journal:  Mol Gen Genet       Date:  1977-01-07

9.  Recovery of structurally intact and infectious poliovirus type 1 from HeLa cells during receptor-mediated endocytosis.

Authors:  P Willingmann; H Barnert; H Zeichhardt; K O Habermehl
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

10.  Myristoyl CoA:protein N-myristoyltransferase activities from rat liver and yeast possess overlapping yet distinct peptide substrate specificities.

Authors:  D A Towler; S P Adams; S R Eubanks; D S Towery; E Jackson-Machelski; L Glaser; J I Gordon
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

View more
  45 in total

1.  The leader polypeptide of Theiler's murine encephalomyelitis virus is required for the assembly of virions in mouse L cells.

Authors:  C Badshah; M A Calenoff; K Rundell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Expression of a membrane-anchored glycoprotein, the influenza virus hemagglutinin, by dicistronic replicons derived from the poliovirus genome.

Authors:  Marco Vignuzzi; Sylvie Gerbaud; Sylvie van der Werf; Nicolas Escriou
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.

Authors:  N Moscufo; M Chow
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Protein engineering and site-directed mutagenesis. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1990-10       Impact factor: 2.926

5.  An improved method for sequencing of RNA templates.

Authors:  O Fichot; M Girard
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

6.  Analysis of translational initiation in coxsackievirus B3 suggests an alternative explanation for the high frequency of R+4 in the eukaryotic consensus motif.

Authors:  Stephanie Harkins; Christopher T Cornell; J Lindsay Whitton
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Myristoylation is important at multiple stages in poliovirus assembly.

Authors:  N Moscufo; J Simons; M Chow
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation.

Authors:  T A Weaver; A T Panganiban
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.

Authors:  D Marc; G Masson; M Girard; S van der Werf
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

10.  Myristylated polyomavirus VP2: role in the life cycle of the virus.

Authors:  N Krauzewicz; C H Streuli; N Stuart-Smith; M D Jones; S Wallace; B E Griffin
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.